-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2010 to Q1 2025.
- Protalix BioTherapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $306K, a 48.8% decline year-over-year.
- Protalix BioTherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1.28M, a 11.6% increase from 2023.
- Protalix BioTherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1.15M, a 83% increase from 2022.
- Protalix BioTherapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $628K, a 57% decline from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)